新冠疫情对宫颈癌筛查评估的影响。
Impact of the Corona Pandemic on Cervical Cancer Screening Assessment.
机构信息
Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany;
Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuremberg (CCC ER-EMN), Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
出版信息
In Vivo. 2024 Mar-Apr;38(2):734-740. doi: 10.21873/invivo.13495.
BACKGROUND/AIM: The global impact of the COVID-19 pandemic resulted in disruptions to healthcare systems throughout the world. The numbers of cytology examinations, human papillomavirus (HPV) tests, and women referred for colposcopy decreased in many countries. There have been no reports on cervical cancer screening in Germany. This study aimed to describe changes in the numbers of colposcopies, cytology examinations, HPV tests, and histological results during the pandemic compared to the pre-pandemic years in order to evaluate the impact of the COVID-19 pandemic on cervical cancer screening.
PATIENTS AND METHODS
The numbers of colposcopies, cytology examinations, HPV tests, and histologic results were analyzed retrospectively for the period January 2018 to December 2022. The 2 years period before the pandemic (2018 and 2019) were compared with the 3 years period of the pandemic (2020-2022).
RESULTS
In total, 6,518 colposcopies were performed in 5,579 women. The numbers of colposcopies, cytology examinations, and high-risk HPV (hrHPV) tests increased during the pandemic years. The number of biopsies per year taken was stable (range=450-554). The relative numbers of cervical intraepithelial neoplasia (CIN) III/HSIL findings were stable, while the numbers of cervical cancers identified increased slightly from 15 (6.6%) in 2018 to 22 (7.4%) in 2022.
CONCLUSION
Increases in numbers of women examined and colposcopies were observed in the years 2021 and 2022 during the pandemic, in comparison to the preceding years. These also led to increases in the figures for cytology, hrHPV, histology, and operations. The onset of the pandemic occurred in the same year as a newly organized screening program started in Germany. The increases might therefore be due to the newly organized screening system.
背景/目的：COVID-19 大流行对全球医疗体系造成了影响。在许多国家，细胞学检查、人乳头瘤病毒（HPV）检测和转诊行阴道镜检查的人数都有所减少。德国尚未有关于宫颈癌筛查的报告。本研究旨在描述大流行期间与大流行前年份相比，阴道镜检查、细胞学检查、HPV 检测和组织学结果数量的变化，以评估 COVID-19 大流行对宫颈癌筛查的影响。
患者和方法
回顾性分析 2018 年 1 月至 2022 年 12 月期间的阴道镜检查、细胞学检查、HPV 检测和组织学结果。将大流行前的 2 年（2018 年和 2019 年）与大流行期间的 3 年（2020-2022 年）进行比较。
结果
共对 5579 名女性进行了 6518 次阴道镜检查。大流行期间，阴道镜检查、细胞学检查和高危型 HPV（hrHPV）检测的数量增加。每年活检的数量保持稳定（范围=450-554）。宫颈上皮内瘤变（CIN）III/HSIL 的相对检出率保持稳定，而宫颈癌的检出数量从 2018 年的 15 例（6.6%）略有增加到 2022 年的 22 例（7.4%）。
结论
与前几年相比，大流行期间的 2021 年和 2022 年接受检查和阴道镜检查的女性人数有所增加。这也导致细胞学、hrHPV、组织学和手术的数量增加。大流行的开始与德国新组织的筛查计划同时发生。因此，这种增加可能是由于新组织的筛查系统。
Zotero 插件